<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue journalpublishing.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">287</article-id><article-id pub-id-type="publisher-id">2009molvis0345</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Polymorphisms in the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes and neovascular age-related macular degeneration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Amy M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Aaron Y.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kulkarni</surname><given-names>Mukti</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Osborn</surname><given-names>Melissa P.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Brantley Jr.</surname><given-names>Milam A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology and Visual Sciences Washington University School of Medicine, St. Louis, MO</aff><aff id="aff2"><label>2</label>Barnes Retina Institute, St. Louis, MO</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Milam A. Brantley Jr., Department of Ophthalmology and Visual Sciences/Campus Box 8096, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO, 63110; Phone: (314) 747-5606, FAX: (314) 747-4121, email: <email xlink:href="Brantley@vision.wustl.edu">Brantley@vision.wustl.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>12</month><year>2009</year></pub-date><volume>15</volume><fpage>2710</fpage><lpage>2719</lpage><history><date date-type="received"><day>20</day><month>9</month><year>2009</year></date><date date-type="accepted"><day>04</day><month>12</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Molecular Vision.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Genetic factors influence an individual&#x02019;s risk for developing neovascular age-related macular degeneration (AMD), a leading cause of irreversible blindness. Previous studies on the potential genetic link between AMD and vascular endothelial growth factor (VEGF), a key regulator of angiogenesis and vascular permeability, have yielded conflicting results. In the present case-control association study, we aimed to determine whether VEGF or its main receptor tyrosine kinase VEGFR-2 is genetically associated with neovascular AMD.</p></sec><sec><title>Methods</title><p>A total of 515 Caucasian patients with neovascular AMD and 253 ethically-matched controls were genotyped for polymorphisms in the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes. A tagging single nucleotide polymorphism (tSNP) approach was employed to cover each gene plus two kilobases on each side, spanning the promoter and 3&#x02032; untranslated regions. SNPs with a minimum allele frequency of 10% were covered by seven tSNPs in <italic>VEGFA</italic> and 20 tSNPs in <italic>VEGFR-2</italic>. Two <italic>VEGFA</italic> SNPs previously linked with AMD, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1413711">rs1413711</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3025039">rs3025039</ext-link>, were also analyzed.</p></sec><sec><title>Results</title><p>The 29 <italic>VEGFA</italic> and <italic>VEGFR-2</italic> SNPs analyzed in our cohort demonstrated no significant association with neovascular AMD. A single rare haplotype in the <italic>VEGFR-2</italic> gene was associated with the presence of neovascular AMD (p=0.034).</p></sec><sec><title>Conclusions</title><p>This study is the first to investigate the association of <italic>VEGFR-2</italic> polymorphisms with AMD and evaluates <italic>VEGFA</italic> genetic variants in the largest neovascular AMD cohort to date. Despite the angiogenic and permeability-enhancing effects of VEGF/VEGFR-2 signaling, we found minimal evidence of a significant link between polymorphisms in the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes and neovascular AMD.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Brantley</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in individuals over the age of 50 in the Western world [<xref ref-type="bibr" rid="r1">1</xref>]. In addition to dietary and environmental risk factors, genetics influences AMD susceptibility [<xref ref-type="bibr" rid="r2">2</xref>]. Recently, single nucleotide polymorphisms (SNPs) in the complement factor H (<italic>CFH</italic>) gene [<xref ref-type="bibr" rid="r3">3</xref>-<xref ref-type="bibr" rid="r5">5</xref>] and the <italic>ARMS2/HTRA1</italic> locus [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>] have been strongly linked to AMD. Common variants in the complement factor B (<italic>CFB</italic>)/complement component 2 (<italic>C2</italic>) [<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r9">9</xref>] and complement component 3 (<italic>C3</italic>) [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r13">13</xref>] genes have also been associated with presence of AMD. Vascular endothelial growth factor (VEGF), coded for by the <italic>VEGFA</italic> gene, is a key mediator of angiogenesis and vascular permeability. Thus, VEGF is a logical candidate for genetically influencing AMD susceptibility, based on its functional relevance to AMD pathophysiology.</p><p>VEGF plays a key role in the angiogenesis, vascular leakage, and inflammation that is characteristic of the neovascular form of advanced AMD [<xref ref-type="bibr" rid="r14">14</xref>]. In recent years, the VEGF signaling pathway has been targeted for inhibition therapy to treat choroidal neovascularization secondary to AMD [<xref ref-type="bibr" rid="r15">15</xref>]. VEGF regulates angiogenesis in the vascular endothelium through the high-affinity receptor tyrosine kinases VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1, KDR) [<xref ref-type="bibr" rid="r16">16</xref>]. Of these two receptors, VEGFR-2 is responsible for the majority of the angiogenic and permeability-enhancing effects of VEGF [<xref ref-type="bibr" rid="r17">17</xref>,<xref ref-type="bibr" rid="r18">18</xref>]. VEGFR-1 regulates VEGF activity in the vascular endothelium by preventing VEGF/VEGFR-2 binding [<xref ref-type="bibr" rid="r17">17</xref>].</p><p>A relationship between the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes and neovascular AMD seems plausible, given the role of choroidal neovascularization in the pathophysiology of late-stage AMD and the importance of the receptor VEGFR-2 in the VEGF-signaling pathways that modulate angiogenesis and vascular permeability. Several small-scale case-control studies have reported associations between various SNPs in <italic>VEGFA</italic> and AMD [<xref ref-type="bibr" rid="r18">18</xref>-<xref ref-type="bibr" rid="r21">21</xref>], but these results have not been confirmed by subsequent studies [<xref ref-type="bibr" rid="r22">22</xref>-<xref ref-type="bibr" rid="r24">24</xref>]. While a recent analysis of <italic>VEGFA</italic> SNPs showed no associations with neovascular AMD, it did suggest that a three-SNP <italic>VEGFA</italic> haplotype increased the risk of neovascular AMD [<xref ref-type="bibr" rid="r25">25</xref>]. To our knowledge, the potential link between <italic>VEGFR-2</italic> and AMD has not been investigated. In this study, we focused on neovascular AMD, as its positive response to anti-VEGF therapy implicates the VEGF pathway in the pathogenesis of this AMD subtype. Using a tagging SNP (tSNP) approach in a large cohort of neovascular AMD patients, we aimed to determine if a genetic association exists between the <italic>VEGFA</italic> or <italic>VEGFR-2</italic> genes and neovascular AMD.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>This retrospective case-control association study was approved by the Washington University Human Research Protection Office and the Barnes Retina Institute Study Center. Research adhered to the tenets of the Declaration of Helsinki and was conducted in accordance with Health Insurance Portability and Accountability Act regulations. All participants were enrolled from the clinical offices of the Barnes Retina Institute, and informed consent was obtained before participation. Participants were identified through chart review, and only Caucasian patients with a diagnosis of neovascular AMD were included. Controls were identified as having no signs of AMD and were recruited from the same locations.</p><p>A total of 768 patients were genotyped for SNPs in the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes using DNA extracted from mouthwash samples. Each participant provided buccal tissue samples by expectorating into 50&#x000a0;ml conical tubes (Falcon; BD Biosciences, San Jose, CA) after vigorously rinsing for 30 s with approximately 20&#x000a0;ml Scope mouthwash (Procter &#x00026; Gamble, Cincinnati, OH). Genomic DNA was prepared from the collected buccal cells using the Gentra Puregene Buccal Cell Kit (Qiagen, Valencia, CA).</p></sec><sec><title>Tagging single nucleotide polymorphism selection</title><p>We employed a tSNP approach to cover the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> genes plus two kilobases (kb) on each side, including the promoter and 3&#x02032; untranslated regions. Using <ext-link ext-link-type="uri" xlink:href="http://hapmap.org">HapMap</ext-link> Project Build 36, we identified the SNPs in each gene with a minimum allele frequency (MAF) of 10% [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. The minimum r<sup>2</sup> value was set to 0.80, and genotypes for the Centre d&#x02019;Etude du Polymorphisme Humain (CEPH) from Utah (CEU) population (Utah residents with ancestry from northern and western Europe) were used. We selected <italic>VEGFA</italic> tSNPs and <italic>VEGFR-2</italic> tSNPs covering the HapMap-identified SNPs through the <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/tagger">Tagger</ext-link> algorithm. Using Sequenom MassARRAY technology (Sequenom Inc., San Diego, CA), study participants were genotyped for these tSNPs, as well as for two additional SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1413711">rs1413711</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025039">rs3025039</ext-link>) previously associated with AMD [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r20">20</xref>].</p></sec><sec><title>Data analysis</title><p>Descriptive statistics for all demographic and clinical variables were calculated, and comparisons were made using the ANOVA test for means with continuous data (e.g., age) and the chi-square test for categorical data (e.g., gender). Genotyping data was loaded into <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/mpg/haploview">Haploview</ext-link> in linkage format to generate allele frequencies, ratios, and p values based on a chi-square test for association of alleles [<xref ref-type="bibr" rid="r26">26</xref>]. The Hardy&#x02013;Weinberg equilibrium test was used to confirm that genotypes fell within a standard distribution. Genotype distributions were analyzed by logistic regression, incorporating adjustments for age and gender. Haplotype blocks encompassing the tested SNPs were defined by 95% confidence intervals and were predicted using Haploview. Statistics were performed with SPSS (version 17; SPSS Inc., Chicago, IL). For all statistical analyses, p&#x0003c;0.05 was considered to be statistically significant, and multiple comparisons were adjusted for by the Bonferroni correction.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Using HapMap and Tagger for tSNP selection, we identified seven <italic>VEGFA</italic> tSNPs and 22 <italic>VEGFR-2</italic> tSNPs to cover both genes. Because two assays failed design, 20 tSNPs in <italic>VEGFR-2</italic> were selected for genotyping. The two failed tSNPs correlated poorly with other SNPs, and alternative SNPs could not be chosen. The 20 genotyped tSNPs in <italic>VEGFR-2</italic> had a mean r<sup>2</sup> of 0.97 and captured 44 of the 46 SNPs with a MAF greater than 10%.</p><p>A total of 515 Caucasian patients with neovascular AMD and 253 ethnically-matched controls were genotyped for this study. Cases and controls had mean ages of 79.2 and 69.3 years, respectively (p&#x0003c;0.001). The case cohort consisted of a lower percentage of males (33.6%) than did the control cohort (43.9%; p=0.005). Adjustments for age and gender were incorporated in the genotype analysis of both <italic>VEGFA</italic> and <italic>VEGFR-2</italic>. All analyzed SNPs conformed to Hardy&#x02013;Weinberg equilibrium in both the case and control populations. Allele distributions did not differ significantly between cases and controls for any of the nine <italic>VEGFA</italic> SNPs (<xref ref-type="table" rid="t1">Table 1</xref>). According to the genotype distribution for these SNPs (<xref ref-type="table" rid="t2">Table 2</xref>), one tSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs699947">rs699947</ext-link>) and one SNP previously associated with AMD (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1413711">rs1413711</ext-link>) demonstrated significant uncorrected p values, but no significant association was found for any <italic>VEGFA</italic> SNP after correcting for multiple comparisons. Allele distributions for the 20 <italic>VEGFR-2</italic> tSNPs showed significant uncorrected p values for three tSNPs, but none remained significant after correcting for multiple comparisons (<xref ref-type="table" rid="t3">Table 3</xref>). No <italic>VEGFR-2</italic> tSNPs were associated with neovascular AMD by genotype distribution (<xref ref-type="table" rid="t4">Table 4</xref>).</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Allele distribution for single nucleotide polymorphisms in <italic>VEGFA</italic></title></caption><table frame="hsides" rules="groups"><col width="61" span="1"/><col width="64" span="1"/><col width="58" span="1"/><col width="60" span="1"/><col width="78" span="1"/><col width="78" span="1"/><col width="96" span="1"/><col width="72" span="1"/><col width="60" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Location in gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genomic location</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variation</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variant allele in controls, n (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variant allele in cases, n (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Odds ratio (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Unadjusted p-value</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Adjusted p-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs699947">rs699947</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032; UTR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43844367<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">267 (52.8)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">500 (48.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.68&#x02013;1.05)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.120<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs25648">rs25648</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43846955<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">98 (19.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188 (18.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.93 (0.71&#x02013;1.22)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.598<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1413711">rs1413711</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43848656<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">240 (47.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">528 (51.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.17 (0.94&#x02013;1.44)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.158<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs833068">rs833068</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43850505<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">153 (30.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">342 (33.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.15 (0.91&#x02013;1.44)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.242<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2146323">rs2146323</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43853073<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">189 (37.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">362 (35.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.91 (0.73&#x02013;1.13)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.376<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025030">rs3025030</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43858565<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67 (13.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">137 (13.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.01 (0.73&#x02013;1.38)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.974<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025035">rs3025035</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43859337<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34 (6.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">77 (7.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.12 (0.74&#x02013;1.70)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.591<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025039">rs3025039</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3&#x02032; UTR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43860514<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">66 (13.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">137 (13.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.02 (0.75&#x02013;1.40)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.889<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10434">rs10434</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">3&#x02032; UTR</td><td valign="top" align="center" rowspan="1" colspan="1">43861190</td><td valign="top" align="center" rowspan="1" colspan="1">G to A</td><td valign="top" align="center" rowspan="1" colspan="1">246 (48.6)</td><td valign="top" align="center" rowspan="1" colspan="1">484 (47.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.76&#x02013;1.16)</td><td valign="top" align="center" rowspan="1" colspan="1">0.549</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr></tbody></table><table-wrap-foot><p>A total of 515 patients with age-related macular degeneration (cases) and 253 ethnically-matched individuals without age-related macular degeneration (controls) were genotyped for nine single nucleotide polymorphisms (SNPs) in the <italic>VEGFA</italic> gene. The Location in gene column refers to the location of the SNP within the <italic>VEGFA</italic> gene. The Genomic location column identifies the specific location of each SNP on Chromosome 6. The Variation column indicates the nature of the polymorphism from the normal allele to the variant allele. The frequency of the minor allele for each SNP was compared in cases and controls by the chi-square test. Odds ratios, 95% confidence intervals (CI), and p-values are reported. Adjusted p-values have been corrected for multiple comparisons using the Bonferroni method.</p></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Genotype distribution for single nucleotide polymorphisms in <italic>VEGFA</italic></title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="63" span="1"/><col width="62" span="1"/><col width="44" span="1"/><col width="37" span="1"/><col width="70" span="1"/><col width="63" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>95% CI</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Unadjusted p-value</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Adjusted p-value</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs699947">rs699947</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.57<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.025<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.223<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.81<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.08<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.05<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs25648">rs25648</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.69<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.53<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.180<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.36<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.86<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1413711">rs1413711</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.96<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.042<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.381<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.98<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs833068">rs833068</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.38<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.02<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.237<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.17<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.65<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.15<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2146323">rs2146323</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.82<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.56<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.20<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.326<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.82<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.40<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025030">rs3025030</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.70<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.254<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.69<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025035">rs3025035</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.19<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.69<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.10<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.230<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1749<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NA<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025039">rs3025039</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.72<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.296<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.000<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.08<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10434">rs10434</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.18<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.099</td><td rowspan="2" valign="top" align="center" colspan="1">0.892</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">AA</td><td valign="top" align="center" rowspan="1" colspan="1">0.66</td><td valign="top" align="center" rowspan="1" colspan="1">0.40</td><td valign="top" align="center" rowspan="1" colspan="1">1.08</td></tr></tbody></table><table-wrap-foot><p>Genotype analysis of <italic>VEGFA</italic> single nucleotide polymorphisms (SNPs) was performed by logistic regression, incorporating adjustments for age and gender. Odds ratios (OR), 95% confidence intervals (CI), and p-values are reported by genotype (normal/variant, variant/variant) for each tested SNP. Adjusted p-values have been corrected for multiple comparisons using the Bonferroni method.</p></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Allele distribution for tagging single nucleotide polymorphisms in <italic>VEGFR-2</italic></title></caption><table frame="hsides" rules="groups"><col width="67" span="1"/><col width="58" span="1"/><col width="60" span="1"/><col width="66" span="1"/><col width="96" span="1"/><col width="90" span="1"/><col width="96" span="1"/><col width="72" span="1"/><col width="66" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Location in gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genomic location</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variation</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variant allele in controls, n (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variant allele in cases, n (%)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Odds ratio (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Unadjusted p-value</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Adjusted p-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7691507">rs7691507</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3&#x02032; UTR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55637758<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95 (18.8)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">191 (18.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.98 (0.75&#x02013;1.29)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.913<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12642307">rs12642307</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55646938<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">142 (28.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">319 (31.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.15 (0.91&#x02013;1.45)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.243<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2125489">rs2125489</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55648240<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58 (11.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">106 (10.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.89 (0.63&#x02013;1.24)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.485<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1531289">rs1531289</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 25<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55649989<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61 (28.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">306 (29.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.04 (0.82&#x02013;1.32)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.730<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17709898">rs17709898</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55652480<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A to G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">146 (39.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">348 (33.8)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.79 (0.64&#x02013;0.99)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.040<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.795<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12505758">rs12505758</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55661655<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55 (10.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">118 (11.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.06 (0.76&#x02013;1.49)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.732<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs13109660">rs13109660</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55665437<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">159 (31.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">378 (36.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.27 (1.01&#x02013;1.59)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.042<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.831<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1870377">rs1870377</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55667731<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">134 (26.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">232 (22.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.81 (0.63&#x02013;1.03)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.087<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7654599">rs7654599</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55670925<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">210 (41.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">418 (40.6)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.96 (0.78&#x02013;1.20)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.731<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17085326">rs17085326</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55672133<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">38 (7.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81 (7.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.05 (0.70&#x02013;1.57)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.807<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2034965">rs2034965</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55672557<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">133 (26.3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">269 (26.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.78&#x02013;1.26)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.944<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10020464">rs10020464</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55673827<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">150 (29.6)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">300 (29.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.98 (0.77&#x02013;1.23)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.834<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305948">rs2305948</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55674315<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61 (12.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89 (8.6)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.69 (0.49&#x02013;0.97)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.034<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7692791">rs7692791</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55674996<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">233 (46.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">486 (47.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.05 (0.85&#x02013;1.30)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.675<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305949">rs2305949</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55675213<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">111 (21.9)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">207 (20.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.69&#x02013;1.16)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.403<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs6837735">rs6837735</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55680572<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">80 (15.8)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">191 (18.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.21 (0.91&#x02013;1.61)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.187<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1531290">rs1531290</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55681319<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A to G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">239 (47.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">509 (49.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.09 (0.88&#x02013;1.35)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.421<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12502008">rs12502008</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intron 1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55685799<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G to T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">180 (35.6)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">368 (35.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.01 (0.81&#x02013;1.26)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.953<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7667298">rs7667298</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032; UTR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55686488<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T to C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">226 (44.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">486 (47.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.11 (0.89&#x02013;1.37)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.352<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2239702">rs2239702</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032; UTR</td><td valign="top" align="center" rowspan="1" colspan="1">55686896</td><td valign="top" align="center" rowspan="1" colspan="1">G to A</td><td valign="top" align="center" rowspan="1" colspan="1">121 (24.9)</td><td valign="top" align="center" rowspan="1" colspan="1">263 (25.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1.03 (0.81&#x02013;1.32)</td><td valign="top" align="center" rowspan="1" colspan="1">0.789</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr></tbody></table><table-wrap-foot><p>A total of 515 patients with age-related macular degeneration (cases) and 253 ethnically-matched individuals without age-related macular degeneration (controls) were genotyped for twenty single nucleotide polymorphisms (SNPs) in the <italic>VEGFR-2</italic> gene. The Location in gene column refers to the location of the SNP within the <italic>VEGFR-2</italic> gene. The Genomic location column identifies the specific location of each SNP on Chromosome 4. The Variation column indicates the nature of the polymorphism from the normal allele to the variant allele. The frequency of the minor allele for each SNP was compared in cases and controls by the chi-square test. Odds ratios, 95% confidence intervals (CI), and p-values are reported. Adjusted p-values have been corrected for multiple comparisons using the Bonferroni method.</p></table-wrap-foot></table-wrap><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Genotype distribution for tagging single nucleotide polymorphisms in <italic>VEGFR-2</italic></title></caption><table frame="hsides" rules="groups"><col width="71" span="1"/><col width="66" span="1"/><col width="42" span="1"/><col width="36" span="1"/><col width="48" span="1"/><col width="70" span="1"/><col width="62" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>OR</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>95% CI</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Unadjusted p-value</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Adjusted p-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7691507">rs7691507</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.71<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.602<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12642307">rs12642307</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.306<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.74<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2125489">rs2125489</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.83<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.54<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.29<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.482<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.19<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24.17<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1531289">rs1531289</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.360<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.34<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.70<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17709898">rs17709898</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.068<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.09<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12505758">rs12505758</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.548<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.68<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107.98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs13109660">rs13109660</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.09<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.75<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.271<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.80<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.78<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1870377">rs1870377</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.96<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.527<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7654599">rs7654599</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.08<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.672<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17085326">rs17085326</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.43<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.665<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.21<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2034965">rs2034965</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.65<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.506<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.18<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.55<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10020464">rs10020464</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.81<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.55<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.93<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305948">rs2305948</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.39<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.250<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.43<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.80<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7692791">rs7692791</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.80<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.834<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305949">rs2305949</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.71<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.605<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.46<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs6837735">rs6837735</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.82<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.82<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.209<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.65<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1531290">rs1531290</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.90<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.605<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.70<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12502008">rs12502008</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.449<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7667298">rs7667298</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.90<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.41<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.259<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.46<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2239702">rs2239702</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.465<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.000<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">AA</td><td valign="top" align="center" rowspan="1" colspan="1">1.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.57</td><td valign="top" align="center" rowspan="1" colspan="1">2.52</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>Genotype analysis of <italic>VEGFR-2</italic> tagging single nucleotide polymorphisms (tSNPs) was performed by logistic regression, incorporating adjustments for age and gender. Odds ratios (OR), 95% confidence intervals (CI), and p-values are reported by genotype (normal/variant, variant/variant) for each tested tSNP. Adjusted p-values have been corrected for multiple comparisons using the Bonferroni method.</p></table-wrap-foot></table-wrap><p>Linkage disequilibrium-based haplotypes were defined for the <italic>VEGFA</italic> and <italic>VEGFR-2</italic> SNPs, resulting in two haplotype blocks for <italic>VEGFA</italic> (<xref ref-type="fig" rid="f1">Figure 1</xref>) and five haplotype blocks for <italic>VEGFR-2</italic> (<xref ref-type="fig" rid="f2">Figure 2</xref>). Haplotype analysis demonstrated no <italic>VEGFA</italic> haplotypes to be associated with neovascular AMD (<xref ref-type="table" rid="t5">Table 5</xref>) but did reveal a mild association of the rarest haplotype (TTT) in <italic>VEGFR-2</italic> haplotype block 3 with neovascular AMD (p=0.034, <xref ref-type="table" rid="t6">Table 6</xref>).</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Linkage disequilibrium map of <italic>VEGFA</italic> single nucleotide polymorphisms. Two haplotype blocks (bolded) were identified for the nine single nucleotide polymorphisms (SNPs) in the vascular endothelial growth factor (<italic>VEGFA</italic>) gene. A linkage disequilibrium map of these haplotype blocks was generated using Haploview. Length of each block is provided in kilobases (kb), and pairwise linkage disequilibrium (D&#x02019;) is given for each SNP combination. Dark red shading denotes D&#x02019; values greater than 0.80, and empty squares indicate D&#x02019; values of 1.0.</p></caption><graphic xlink:href="mv-v15-2710-f1"/></fig><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Linkage disequilibrium map of <italic>VEGFR-2</italic> tagging single nucleotide polymorphisms. Five haplotype blocks were identified for the 20 tagging single nucleotide polymorphisms (tSNPs) in the vascular endothelial growth factor receptor-2 (<italic>VEGFR-2</italic>) gene. A linkage disequilibrium map of these haplotype blocks was generated using Haploview. Length of each block is provided in kilobases (kb), and pairwise linkage disequilibrium (D&#x02019;) is given for each SNP combination. Dark red shading denotes D&#x02019; values greater than 0.80, and empty squares indicate D&#x02019; values of 1.0.</p></caption><graphic xlink:href="mv-v15-2710-f2"/></fig><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>Haplotype analysis of <italic>VEGFA</italic></title></caption><table frame="hsides" rules="groups"><col width="65" span="1"/><col width="54" span="1"/><col width="61" span="1"/><col width="55" span="1"/><col width="61" span="1"/><col width="65" span="1"/><col width="65" span="1"/><col width="53" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 1</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 2</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 3</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 4</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 5</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Frequency in cases</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Frequency in controls</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p-value</bold></th></tr></thead><tbody><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 1</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs699947">rs699947</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs25648">rs25648</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1413711">rs1413711</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs833068">rs833068</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2146323">rs2146323</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.329<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.292<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.139<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.176<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.193<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.428<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.177<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.166<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.592<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.169<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.171<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.910<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.133<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.153<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.282<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 2</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs3025039">rs3025039</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10434">rs10434</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.470<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.486<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.549<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.397<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.383<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.606<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T</td><td valign="top" align="center" rowspan="1" colspan="1">G</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">0.133</td><td valign="top" align="center" rowspan="1" colspan="1">0.130</td><td valign="top" align="center" rowspan="1" colspan="1">0.889</td></tr></tbody></table><table-wrap-foot><p>Two haplotype blocks were identified for the tested single nucleotide polymorphisms (SNPs) in <italic>VEGFA</italic> using Haploview. Haplotype frequencies in neovascular age-related macular degeneration patients (cases) and participants without age-related macular degeneration (controls) are reported with corresponding p-values. Haplotypes with frequencies above 0.01 are included in the table.</p></table-wrap-foot></table-wrap><table-wrap id="t6" position="float"><label>Table 6</label><caption><title>Haplotype analysis of <italic>VEGFR-2</italic></title></caption><table frame="hsides" rules="groups"><col width="67" span="1"/><col width="67" span="1"/><col width="67" span="1"/><col width="67" span="1"/><col width="61" span="1"/><col width="65" span="1"/><col width="65" span="1"/><col width="52" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 1</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 2</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 3</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 4</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP 5</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Frequency in cases</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Frequency in controls</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p-value</bold></th></tr></thead><tbody><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 1</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1531289">rs1531289</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17709898">rs17709898</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12505758">rs12505758</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs13109660">rs13109660</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1870377">rs1870377</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.351<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.304<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.066<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.217<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.257<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.087<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.182<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.182<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.992<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.105<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.123<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.302<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.113<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.102<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.514<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.015<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.248<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 2</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7654599">rs7654599</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs17085326">rs17085326</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.835<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.406<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.415<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.731<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.079<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.075<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.807<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 3</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs10020464">rs10020464</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305948">rs2305948</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7692791">rs7692791</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.463<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.455<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.772<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.246<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.248<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.910<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.196<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.170<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.230<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.086<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.121<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.034<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 4</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305949">rs2305949</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs6837735">rs6837735</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.614<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.623<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.735<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.201<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.219<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.403<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.185<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.158<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.187<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Block 5</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs12502008">rs12502008</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7667298">rs7667298</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2239702">rs2239702</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.357<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.356<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.953<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.255<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.249<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.789<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.217<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.198<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.394<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">G</td><td valign="top" align="center" rowspan="1" colspan="1">C</td><td valign="top" align="center" rowspan="1" colspan="1">G</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">0.171</td><td valign="top" align="center" rowspan="1" colspan="1">0.198</td><td valign="top" align="center" rowspan="1" colspan="1">0.199</td></tr></tbody></table><table-wrap-foot><p>Five haplotype blocks were identified for the tagging single nucleotide polymorphisms (tSNPs) in <italic>VEGFR-2</italic> using Haploview. Haplotype frequencies in neovascular age-related macular degeneration patients (cases) and participants without age-related macular degeneration (controls) are reported with corresponding p-values. Haplotypes with frequencies above 0.01 are included in the table.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>We analyzed nine SNPs in <italic>VEGFA</italic> and 20 tSNPs in <italic>VEGFR-2</italic> using a tSNP approach designed to cover both genes. The results of this study show little evidence of association with neovascular AMD in our cohort of 515 Caucasian patients.</p><p>Previous investigation of <italic>VEGFA</italic> and AMD has yielded conflicting results. A few smaller-scale case-control studies have reported significant associations for various SNPs in <italic>VEGFA</italic> [<xref ref-type="bibr" rid="r18">18</xref>-<xref ref-type="bibr" rid="r21">21</xref>], but the validity of these results remains unconfirmed [<xref ref-type="bibr" rid="r22">22</xref>-<xref ref-type="bibr" rid="r24">24</xref>]. The only one of these studies to investigate a large neovascular AMD cohort (n=342) using a comprehensive tSNP approach found no link between <italic>VEGFA</italic> tSNPs and development of neovascular AMD [<xref ref-type="bibr" rid="r22">22</xref>]. More recently, a single haplotype was shown to be weakly associated with neovascular AMD in a moderately-sized cohort (n=211), although no associations were found with individual <italic>VEGFA</italic> SNPs [<xref ref-type="bibr" rid="r25">25</xref>]. In the present study, we found no association between neovascular AMD and <italic>VEGFA</italic> SNPs or haplotypes. These discrepant findings may be due to inadequate sample size in the early studies or to the ethnic composition of study populations. Results could also be biased by genotyping error or confounding effects due to statistically significant variables such as age, gender, or other SNPs known to be associated with AMD. As a whole, the studies performed to date provide little evidence that <italic>VEGFA</italic> polymorphisms exert any significant influence on risk of neovascular AMD.</p><p>This is the first study to investigate the relationship between variants in <italic>VEGFR-2</italic> and AMD. One of two receptor tyrosine kinases involved in VEGF signaling pathways, VEGFR-2 mediates the majority of the angiogenic and permeability-enhancing effects of VEGF [<xref ref-type="bibr" rid="r17">17</xref>]. The importance of VEGFR-2 in developmental angiogenesis and hematopoiesis, as demonstrated by the abnormal vasculature of <italic>VEGFR-2</italic> knockout mice [<xref ref-type="bibr" rid="r27">27</xref>], suggests a link between the VEGF/VEGFR-2 pathway and retinal pathology. While VEGF and its receptors play a key role in tumor angiogenesis and other pathological conditions [<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r28">28</xref>,<xref ref-type="bibr" rid="r29">29</xref>], a limited number of gene association studies have been performed for VEGF receptor genes. Recently, polymorphisms in <italic>VEGFR-1</italic> and <italic>VEGFR-2</italic> were reported to be associated with sarcoidosis, an inflammatory condition with a hypothesized antigenic stimulus [<xref ref-type="bibr" rid="r30">30</xref>]. Variants in <italic>VEGFR-2</italic> have also been linked with heart disease and may influence the risk of developing breast cancer [<xref ref-type="bibr" rid="r31">31</xref>-<xref ref-type="bibr" rid="r33">33</xref>]. In our large neovascular AMD cohort, no associations were found for any <italic>VEGFR-2</italic> tSNPs by allele or genotype analysis. Haplotype analysis, however, did show a single rare haplotype to be mildly associated with AMD.</p><p>This study is limited by its retrospective design, which did not allow for assessment of the predictive value of <italic>VEGFA</italic> and <italic>VEGFR-2</italic>. However, in light of our negative findings, it is doubtful that a prospective study would contribute significantly to our knowledge base. This study was designed to investigate common polymorphisms that might be associated with neovascular AMD risk, and it remains possible that rare variants with MAFs less than 10% could play a role in neovascular AMD development. Due to tSNP assay failure, two of the 46 <italic>VEGFR-2</italic> SNPs with a MAF greater than 10% were poorly tagged. The 20 successful <italic>VEGFR-2</italic> tSNPs in our study covered the polymorphisms previously found to be associated with human diseases: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1870377">rs1870377</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2071559">rs2071559</ext-link> (covered by <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7667298">rs7667298</ext-link>), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2125489">rs2125489</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2305948">rs2305948</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7667298">rs7667298</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs7691507">rs7691507</ext-link> [<xref ref-type="bibr" rid="r30">30</xref>-<xref ref-type="bibr" rid="r33">33</xref>].</p><p>In summary, this study is the first to investigate the association of <italic>VEGFR-2</italic> polymorphisms with AMD and evaluates <italic>VEGFA</italic> genetic variants in the largest neovascular AMD cohort to date. Although both VEGF and its receptors have been implicated in the pathophysiology of diseases such as AMD, we found minimal evidence that polymorphisms in <italic>VEGFA</italic> and <italic>VEGFR-2</italic> contribute significantly to risk of neovascular AMD.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the Human Genetics Division Genotyping Core at the Washington University School of Medicine for assisting with genotyping and the physicians of the Barnes Retina Institute for generously contributing their time and patients to this study. This work was supported by the Jahnigen Career Development Award from the American Geriatrics Society (M.A.B.), the Carl M. &#x00026; Mildred A. Reeves Foundation (M.A.B.), NEI Core Grant 5 P30 EY02687, and a grant from Research to Prevent Blindness to the Washington University School of Medicine Department of Ophthalmology and Visual Sciences.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>DS</given-names></name><name><surname>O'Colmain</surname><given-names>BJ</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>B</given-names></name><name><surname>Tomany</surname><given-names>SC</given-names></name><name><surname>McCarty</surname><given-names>C</given-names></name><name><surname>de Jong</surname><given-names>PT</given-names></name><name><surname>Nemesure</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Kempen</surname><given-names>J</given-names></name><collab>Eye Diseases Prevalence Research Group.</collab></person-group><article-title>Prevalence of age-related macular degeneration in the United States.</article-title><source>Arch Ophthalmol</source><year>2004</year><volume>122</volume><fpage>564</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15078675</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montezuma</surname><given-names>SR</given-names></name><name><surname>Sobrin</surname><given-names>L</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Review of genetics in age-related macular degeneration.</article-title><source>Semin Ophthalmol</source><year>2007</year><volume>22</volume><fpage>229</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18097986</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><name><surname>Tsai</surname><given-names>JY</given-names></name><name><surname>Sackler</surname><given-names>RS</given-names></name><name><surname>Haynes</surname><given-names>C</given-names></name><name><surname>Henning</surname><given-names>AK</given-names></name><name><surname>SanGiovanni</surname><given-names>JP</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Mayne</surname><given-names>ST</given-names></name><name><surname>Bracken</surname><given-names>MB</given-names></name><name><surname>Ferris</surname><given-names>FL</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>Complement factor H polymorphism in age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>385</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15761122</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Ritter</surname><given-names>R</given-names><suffix>3rd</suffix></name><name><surname>Abel</surname><given-names>KJ</given-names></name><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Panhuysen</surname><given-names>C</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name></person-group><article-title>Complement factor H polymorphism and age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>421</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15761121</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Kwan</surname><given-names>SY</given-names></name><name><surname>Noureddine</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Complement factor H variant increases the risk of age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>419</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15761120</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>SA</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Keilhauer</surname><given-names>CN</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name></person-group><article-title>Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3227</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">16174643</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsdottir</surname><given-names>J</given-names></name><name><surname>Conley</surname><given-names>YP</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Mah</surname><given-names>TS</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Gorin</surname><given-names>MB</given-names></name></person-group><article-title>Susceptibility genes for age-related maculopathy on chromosome 10q26.</article-title><source>Am J Hum Genet</source><year>2005</year><volume>77</volume><fpage>389</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">16080115</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>B</given-names></name><name><surname>Merriam</surname><given-names>JE</given-names></name><name><surname>Zernant</surname><given-names>J</given-names></name><name><surname>Hancox</surname><given-names>LS</given-names></name><name><surname>Taiber</surname><given-names>AJ</given-names></name><name><surname>Gehrs</surname><given-names>K</given-names></name><name><surname>Cramer</surname><given-names>K</given-names></name><name><surname>Neel</surname><given-names>J</given-names></name><name><surname>Bergeron</surname><given-names>J</given-names></name><name><surname>Barile</surname><given-names>GR</given-names></name><name><surname>Smith</surname><given-names>RT</given-names></name></person-group><article-title>AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variant in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>458</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16518403</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Fagerness</surname><given-names>J</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1055</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16936732</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>JB</given-names></name><name><surname>Fagerness</surname><given-names>JA</given-names></name><name><surname>Reynolds</surname><given-names>RC</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Variation in complement factor 3 is associated with risk of age-related macular degeneration.</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>1200</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">17767156</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Sepp</surname><given-names>T</given-names></name><name><surname>Matharu</surname><given-names>BK</given-names></name><name><surname>Khan</surname><given-names>JC</given-names></name><name><surname>Thurlby</surname><given-names>DA</given-names></name><name><surname>Shahid</surname><given-names>H</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Armbrecht</surname><given-names>AM</given-names></name><name><surname>Dhillon</surname><given-names>B</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Redmond</surname><given-names>E</given-names></name><name><surname>Bird</surname><given-names>AC</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><collab>Genetic Factors in AMD Study Group.</collab></person-group><article-title>Genetic Factors in AMD Study Group. Complement C3 variant and the risk of age-related macular degeneration.</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>553</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17634448</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Anderson</surname><given-names>BM</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name></person-group><article-title>C3 R102G polymorphism increases risk of age-related macular degeneration.</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>1821</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18325906</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Fridley</surname><given-names>BL</given-names></name><name><surname>James</surname><given-names>KM</given-names></name><name><surname>Sharma</surname><given-names>AK</given-names></name><name><surname>Cunningham</surname><given-names>JM</given-names></name><name><surname>Tosakulwong</surname><given-names>N</given-names></name></person-group><article-title>Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study.</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e3813</fpage><pub-id pub-id-type="pmid">19043567</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Le Couter</surname><given-names>J</given-names></name></person-group><article-title>The biology of VEGF and its receptors.</article-title><source>Nat Med</source><year>2003</year><volume>9</volume><fpage>669</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12778165</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubschman</surname><given-names>JP</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Schwartz</surname><given-names>SD</given-names></name></person-group><article-title>Age-related macular degeneration: experimental and emerging treatments.</article-title><source>Clin Ophthalmol</source><year>2009</year><volume>3</volume><fpage>167</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19668561</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veikkola</surname><given-names>T</given-names></name><name><surname>Karkkainen</surname><given-names>M</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name></person-group><article-title>Regulation of angiogenesis via vascular endothelial growth factor receptors.</article-title><source>Cancer Res</source><year>2000</year><volume>60</volume><fpage>203</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10667560</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grisanti</surname><given-names>S</given-names></name><name><surname>Tatar</surname><given-names>O</given-names></name></person-group><article-title>The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.</article-title><source>Prog Retin Eye Res</source><year>2008</year><volume>27</volume><fpage>372</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">18621565</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name><name><surname>Kenealy</surname><given-names>SJ</given-names></name><name><surname>Hauser</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Functional candidate genes in age-related macular degeneration: significant association with VEGF, VDLR, and LRP6.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>329</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">16384981</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>AJ</given-names></name><name><surname>Carter</surname><given-names>JG</given-names></name><name><surname>Lovell</surname><given-names>HC</given-names></name><name><surname>Ramsden</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>SJ</given-names></name><name><surname>Yeung</surname><given-names>A</given-names></name><name><surname>Escardo</surname><given-names>J</given-names></name><name><surname>Atan</surname><given-names>D</given-names></name></person-group><article-title>VEGF polymorphisms are associated with neovascular age-related macular degeneration.</article-title><source>Hum Mol Genet</source><year>2006</year><volume>15</volume><fpage>2955</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16940309</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JM</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Tsai</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tseng</surname><given-names>SH</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name></person-group><article-title>Vascular Endothelial Growth Factor Gene Polymorphisms in Age-related Macular Degeneration.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>1045</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">18378209</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janik-Papis</surname><given-names>K</given-names></name><name><surname>Zaras</surname><given-names>M</given-names></name><name><surname>Krzyzanowska</surname><given-names>A</given-names></name><name><surname>Wozniak</surname><given-names>K</given-names></name><name><surname>Blasiak</surname><given-names>J</given-names></name><name><surname>Szaflik</surname><given-names>J</given-names></name><name><surname>Szaflik</surname><given-names>JP</given-names></name></person-group><article-title>Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.</article-title><source>Exp Mol Pathol</source><year>2009</year><volume>87</volume><fpage>234</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19761764</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>AJ</given-names></name><name><surname>Islam</surname><given-names>FM</given-names></name><name><surname>Guymer</surname><given-names>RH</given-names></name><name><surname>Cain</surname><given-names>M</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name></person-group><article-title>A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>2148</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18079689</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boekhoorn</surname><given-names>SS</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>de Jong</surname><given-names>PT</given-names></name><name><surname>Vingerling</surname><given-names>JR</given-names></name></person-group><article-title>Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.</article-title><source>Ophthalmology</source><year>2008</year><volume>115</volume><fpage>1899</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">18708255</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>Hamon</surname><given-names>SC</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Weleber</surname><given-names>RG</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name></person-group><article-title>Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.</article-title><source>J Med Genet</source><year>2009</year><volume>46</volume><fpage>300</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19015224</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>GJ</given-names></name><name><surname>Silvestri</surname><given-names>G</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Chakravarthy</surname><given-names>U</given-names></name><name><surname>Hughes</surname><given-names>AE</given-names></name></person-group><article-title>VEGF and age-related macular degeneration.</article-title><source>Ophthalmology</source><year>2009</year><volume>116</volume><fpage>1227</fpage><pub-id pub-id-type="pmid">19486801</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalaby</surname><given-names>F</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Yamaguchi</surname><given-names>TP</given-names></name><name><surname>Gertsenstein</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>XF</given-names></name><name><surname>Breitman</surname><given-names>ML</given-names></name><name><surname>Schuh</surname><given-names>AC</given-names></name></person-group><article-title>Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.</article-title><source>Nature</source><year>1995</year><volume>376</volume><fpage>62</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7596435</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>LS</given-names></name></person-group><article-title>VEGF-targeted therapy: therapeutic potential and recent advances.</article-title><source>Oncologist</source><year>2005</year><volume>10</volume><fpage>382</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15967832</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrillo de Santa Pau</surname><given-names>E</given-names></name><name><surname>Arias</surname><given-names>FC</given-names></name><name><surname>Caso Pel&#x000e1;ez</surname><given-names>E</given-names></name><name><surname>Mu&#x000f1;oz Molina</surname><given-names>GM</given-names></name><name><surname>S&#x000e1;nchez Hern&#x000e1;ndez</surname><given-names>I</given-names></name><name><surname>Muguruza Trueba</surname><given-names>I</given-names></name><name><surname>Moreno Balsalobre</surname><given-names>R</given-names></name><name><surname>Sacrist&#x000e1;n L&#x000f3;pez</surname><given-names>S</given-names></name><name><surname>G&#x000f3;mez Pinillos</surname><given-names>A</given-names></name><name><surname>del Val Toledo Lobo</surname><given-names>M</given-names></name></person-group><article-title>Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.</article-title><source>Cancer</source><year>2009</year><volume>115</volume><fpage>1701</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19197998</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabst</surname><given-names>S</given-names></name><name><surname>Karpushova</surname><given-names>A</given-names></name><name><surname>D&#x000ec;az-Lacava</surname><given-names>A</given-names></name><name><surname>Herms</surname><given-names>S</given-names></name><name><surname>Walier</surname><given-names>M</given-names></name><name><surname>Zimmer</surname><given-names>S</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name><name><surname>Nickenig</surname><given-names>G</given-names></name><name><surname>N&#x000f6;then</surname><given-names>MM</given-names></name><name><surname>Wienker</surname><given-names>TF</given-names></name><name><surname>Groh&#x000e9;</surname><given-names>C</given-names></name></person-group><article-title>VEGF gene haplotypes are associated with sarcoidosis.</article-title><source>Chest</source><year>2009</year><pub-id pub-id-type="pmid">19197998</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Lou</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Hui</surname><given-names>R</given-names></name></person-group><article-title>Polymorphisms of <italic>KDR</italic> gene are associated with coronary heart disease.</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>50</volume><fpage>760</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17707181</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000f6;rsti</surname><given-names>A</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name><name><surname>Altieri</surname><given-names>A</given-names></name><name><surname>Johansson</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>K</given-names></name><name><surname>Enquist</surname><given-names>K</given-names></name><name><surname>Grzybowska</surname><given-names>E</given-names></name><name><surname>Pamula</surname><given-names>J</given-names></name><name><surname>Pekala</surname><given-names>W</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Lenner</surname><given-names>P</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.</article-title><source>Breast Cancer Res Treat</source><year>2007</year><volume>101</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16807673</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>BP</given-names></name><name><surname>Radovich</surname><given-names>M</given-names></name><name><surname>Sledge</surname><given-names>GW</given-names></name><name><surname>Robarge</surname><given-names>JD</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Storniolo</surname><given-names>AM</given-names></name><name><surname>Lemler</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>AT</given-names></name><name><surname>Hancock</surname><given-names>BA</given-names></name><name><surname>Stout</surname><given-names>M</given-names></name><name><surname>Skaar</surname><given-names>T</given-names></name><name><surname>Flockhart</surname><given-names>DA</given-names></name></person-group><article-title>Association of polymorphisms of angiogenesis genes with breast cancer.</article-title><source>Breast Cancer Res Treat</source><year>2008</year><volume>111</volume><fpage>157</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">17891484</pub-id></mixed-citation></ref></ref-list></back></article>